| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.42 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |